Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations

Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations

Cefiderocol is a novel siderophore cephalosporin antibacterial with activity against carbapenem-resistant Gram-negative bacteria including Pseudomonas aeruginosa. We report a medically complex patient treated with compassionate use cefiderocol for an empyema caused by extensively drug-resistant P. a...

Full description

Bibliographic Details
Main Authors: Wesley D. Kufel, Jeffrey M. Steele, Scott W. Riddell, Zachary Jones, Pegah Shakeraneh, Timothy P. Endy
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:IDCases
Subjects:
Cefiderocol
Pseudomonas aeruginosa
Antibacterial resistance
Siderophore
Susceptibility testing
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250920301712

Internet

http://www.sciencedirect.com/science/article/pii/S2214250920301712

Similar Items